Seattle-based ModernVivo is using AI to help scientists design preclinical studies for drug discovery. The goal: better experiments that are also faster, cheaper and less reliant on animals.

“You’d be shocked at the way scientists design their experiments,” co-founder Ian Levine told GeekWire. “It’s very manual.”

To design experiments, scientists typically enter keywords into PubMed or another database, receiving hundreds or thousands of results. They then go through each complex paper, typically 30 pages long, to find information relevant to the experiment they’re planning.

Levine spent thousands of hours manually combing through scientific…

Read the full article at GEEKWIRE.COM